Presentation is loading. Please wait.

Presentation is loading. Please wait.

Lobectomy for Lung Cancer at Veterans Administration Medical Center Versus Academic Medical Center  Travis Geraci, MD, Vanessa Baratta, MD, John Young,

Published byΕφροσύνη Μεταξάς Modified over 5 years ago

Similar presentations

Presentation on theme: "Lobectomy for Lung Cancer at Veterans Administration Medical Center Versus Academic Medical Center  Travis Geraci, MD, Vanessa Baratta, MD, John Young,"— Presentation transcript:

1 Lobectomy for Lung Cancer at Veterans Administration Medical Center Versus Academic Medical Center 
Travis Geraci, MD, Vanessa Baratta, MD, John Young, MD, Steven Milman, MD, Ann-Marie Dunican, MD, Richard N. Jones, ScD, Thomas Ng, MD  The Annals of Thoracic Surgery  Volume 103, Issue 6, Pages (June 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Overall survival, matched comparison for stage I (IA and IB), academic medical center (AMC) (solid line) 5-year survival 68% (median 93 months) versus Veterans Administration Medical Center (VAMC) (dotted line) 5-year survival 69% (median 111 months; p = 0.95 by log rank). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Lobectomy for Lung Cancer at Veterans Administration Medical Center Versus Academic Medical Center  Travis Geraci, MD, Vanessa Baratta, MD, John Young,"

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Robot-Assisted Thoracoscopic Lobectomy for Early-Stage Lung Cancer

Robot-Assisted Thoracoscopic Lobectomy for Early-Stage Lung Cancer
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Thomas J. Birdas, MD, Richard P. M

Thomas J. Birdas, MD, Richard P. M
Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis  Amgad El-Sherif, MD, William E. Gooding, MS,

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis  Amgad El-Sherif, MD, William E. Gooding, MS,
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer  Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer  Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Robot-Assisted Lobectomy for Early-Stage Lung Cancer: Report of 100 Consecutive Cases  Farid Gharagozloo, MD, Marc Margolis, MD, Barbara Tempesta, MS,

Robot-Assisted Lobectomy for Early-Stage Lung Cancer: Report of 100 Consecutive Cases  Farid Gharagozloo, MD, Marc Margolis, MD, Barbara Tempesta, MS,
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery 

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery 
Second Primary Lung Cancers: Smokers Versus Nonsmokers After Resection of Stage I Lung Adenocarcinoma  R. Taylor Ripley, MD, Robert R. McMillan, MD, MPH,

Second Primary Lung Cancers: Smokers Versus Nonsmokers After Resection of Stage I Lung Adenocarcinoma  R. Taylor Ripley, MD, Robert R. McMillan, MD, MPH,
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,
Risk Factors of Acute Kidney Injury According to RIFLE Criteria After Lung Cancer Surgery  Marc Licker, MD, Vanessa Cartier, MD, John Robert, MD, John.

Risk Factors of Acute Kidney Injury According to RIFLE Criteria After Lung Cancer Surgery  Marc Licker, MD, Vanessa Cartier, MD, John Robert, MD, John.
Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Similar presentations

Ads by Google